Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Endometrial Neoplasms
×
Cisplatin
×
Head & Neck
×
Clear all
Filters
3
NCT05007106
2025-08-14
KEYVIBE-005
Merck Sharp & Dohme LLC
Phase 2
Completed
613 enrolled
NCT02433626
2019-02-01
COTI2-101
Critical Outcome Technologies Inc.
Phase 1
Unknown
51 enrolled